Free Trial

Bavarian Nordic (OTCMKTS:BVNRY) Sets New 12-Month High - Here's What Happened

Bavarian Nordic logo with Medical background

Key Points

  • Bavarian Nordic shares reached a new 52-week high of $13.00, closing at $12.35 with a trading volume of 20,362 shares.
  • The company reported $0.23 EPS for the last quarter, with a net margin of 21.95% and projected annual EPS of 0.67.
  • Bavarian Nordic focuses on developing and commercializing life-saving vaccines for smallpox, monkeypox, rabies, tick-borne encephalitis, and Ebola.
  • MarketBeat previews top five stocks to own in November.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report)'s share price reached a new 52-week high on Wednesday . The stock traded as high as $13.00 and last traded at $12.35, with a volume of 20362 shares changing hands. The stock had previously closed at $11.76.

Bavarian Nordic Trading Up 6.0%

The company has a market cap of $2.96 billion, a P/E ratio of 14.32 and a beta of 1.27. The company's fifty day moving average is $12.16 and its 200 day moving average is $9.95.

Bavarian Nordic (OTCMKTS:BVNRY - Get Free Report) last announced its quarterly earnings results on Friday, August 22nd. The company reported $0.23 earnings per share (EPS) for the quarter. The business had revenue of $251.14 million for the quarter. Bavarian Nordic had a net margin of 21.95% and a return on equity of 12.35%. Analysts anticipate that Bavarian Nordic will post 0.67 EPS for the current year.

About Bavarian Nordic

(Get Free Report)

Bavarian Nordic A/S develops, manufactures, and commercializes life-saving vaccines. The company offers non-replicating smallpox and monkeypox vaccines under the IMVAMUNE, IMVANEX, and JYNNEOS names; rabies vaccine for human use under the Rabipur/RabAvert name; tick-borne encephalitis vaccine under the Encepur name; and Ebola vaccine under the MVABEA name.

Featured Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Bavarian Nordic Right Now?

Before you consider Bavarian Nordic, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bavarian Nordic wasn't on the list.

While Bavarian Nordic currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

 The Best Nuclear Energy Stocks to Buy Cover

Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.

Get This Free Report
Like this article? Share it with a colleague.